Abstract
Influenza viruses, unlike other viruses for which vaccines have been developed, undergo rapid and unpredictable antigenic variation in the hemagglutinin (HA), the surface glycoprotein primarily responsible for eliciting neutralizing antibodies during infection. Because of this antigenic variability and its consequences, the World Health Organization (WHO) in 1947 established an international network of collaborating laboratories to monitor the emergence and spread of new epidemic and pandemic strains of influenza. This network now includes three international WHO collaborating centers and over 100 WHO national collaborating laboratories. The primary purpose of this network is to detect, through laboratory surveillance, the emergence and spread of antigenic variants of influenza that may signal a need to update the formulation of the influenza vaccine. This laboratory surveillance network has provided the strains needed to update the vaccine as well as a repository of influenza viruses useful for studying the antigenic and genetic evolution of this virus. Knowledge gained from molecular studies on the evolution of drift variants and on the emergence of pandemic strains has made influenza a useful model for understanding the potential threat of other emerging or reemerging microbial diseases.
Article PDF
Similar content being viewed by others
References
Liu K-J, Kendal A. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Pub Health 1987; 77: 712–716.
Webster R, Bean W, Gorman O, Chambers T, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152–179.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 1989/90 season. WHO Weekly Epidemiol Rec 1989; 8: 53–56.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 1991/92 season. WHO Weekly Epidemiol Rec 1991; 9: 57–60.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 1992/93 season. WHO Weekly Epidemiol Rec 1992; 9: 57–60.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 1993/94 season. WHO Weekly Epidemiol Rec 1993; 9: 57–60.
Cox N, Xu X, Bender C, Kendal A, Regnery H, Hemphill M, Rota P. Evolution of hemagglutinin in epidemic variants and selection of vaccine viruses. In: Hannoun C, et al., eds. Options for the control of influenza II. Amsterdam: Elsevier / North Holland, 1993: 223–230.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cox, N.J., Brammer, T.L. & Regnery, H.L. Influenza: Global surveillance for epidemic and pandemic variants. Eur J Epidemiol 10, 467–470 (1994). https://doi.org/10.1007/BF01719678
Issue Date:
DOI: https://doi.org/10.1007/BF01719678